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ABSTRACT
Despite the central role of quantitative PCR (qPCR)
in the quantification of mRNA transcripts, most
analyses of qPCR data are still delegated to the soft-
ware that comes with the qPCR apparatus. This is
especially true for the handling of the fluorescence
baseline. This article shows that baseline estimation
errors are directly reflected in the observed PCR
efficiency values and are thus propagated exponen-
tially in the estimated starting concentrations as
well as ‘fold-difference’ results. Because of the
unknown origin and kinetics of the baseline fluores-
cence, the fluorescence values monitored in the ini-
tial cycles of the PCR reaction cannot be used to
estimate a useful baseline value. An algorithm that
estimates the baseline by reconstructing the log-
linear phase downward from the early plateau
phase of the PCR reaction was developed and
shown to lead to very reproducible PCR efficiency
values. PCR efficiency values were determined per
sample by fitting a regression line to a subset of
data points in the log-linear phase. The variability,
as well as the bias, in qPCR results was significantly
reduced when the mean of these PCR efficiencies
per amplicon was used in the calculation of an esti-
mate of the starting concentration per sample.
INTRODUCTION
During the last decade, quantitative real-time reverse tran-
scriptase PCR, or qPCR for short, has become the method
of choice for the quantiﬁcation of mRNA transcripts (1,2).
Despite the large number of papers on qPCR data anal-
ysis, most researchers still delegate this analysis to the
software that comes with their PCR system (3). The main-
stream of qPCR data analysis is based on the direct appli-
cation of the basic equation for PCR ampliﬁcation (Box 1;
Equation 1), which describes the exponential increase in
observed ﬂuorescence when the PCR reaction is moni-
tored using a ﬂuorescent DNA-binding dye (e.g. SYBR
Green I) (4). Alternative qPCR data analysis methods,
such as those based on nonlinear curve ﬁtting (5–7) will
be considered in a separate section of this article.
The calculation of starting concentrations in qPCR ana-
lysis requires an estimate of the PCR eﬃciency, the setting
of a ﬂuorescence threshold and the determination of the Ct
value, which is the fractional cycle number that is required
to reach this threshold (8). Originally, qPCR analysis used
a PCR eﬃciency value that was assumed to be constant (8)
but currently the eﬃciency is derived from a standard
curve (2,9) or calculated as the mean eﬃciency per ampli-
con (10–12). Analysis methods that are based on the
PCR eﬃciency per sample (13–15) were shown to give
highly variable results (10–12,16,17). This high variability
remained a conundrum until it became clear that the
observed PCR eﬃciency is strongly aﬀected by the applied
baseline estimate (Figure 1A). In the real-time PCR chem-
istry considered in this article, the baseline ﬂuorescence is
due to the ﬂuorescence of unbound ﬂuorochrome (e.g.
SYBR Green I), and to ﬂuorochrome bound to, among
others, double strand cDNA and primers annealing
to nontarget DNA sequences (Figure 1B). Other ﬂuores-
cence sources also contribute to the baseline ﬂuorescence.
Although it was reported that a baseline has to be
subtracted before a valid PCR eﬃciency value can be
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determined (18) and shortcomings in the baseline subtrac-
tion methods in system software have been recognized
(19,20), the need to determine the correct baseline value
has mainly been ignored in the literature. It has been
addressed in some papers (7,21) and then it is mainly dis-
cussed in the context of the ﬁt of the employed analysis
model (5,7). Validation of the baseline estimation relies on
visual inspection of the shape of the resulting dataset
(2,20,21).
The current study shows how an improper baseline
setting severely aﬀects the estimated PCR eﬃciencies and
will thus increase the variability as well as the bias in the
reported absolute and relative levels of gene expression.
To solve these issues, an algorithm to estimate the optimal
baseline for each individual sample was developed.
The body of this article deals chronologically with
each of the issues required for qPCR data analysis, thus
aiming at presenting a comprehensive qPCR data analysis
protocol (Figure 1C). The described methods have been
incorporated into the LinRegPCR quantitative PCR data
analysis program (version 11.0, download: http://
LinRegPCR.HFRC.nl).
MATERIALS AND METHODS
Tissue samples
Thirty hearts of chicken embryos of 3 days of develop-
ment were isolated and separated into the ﬁve diﬀerent
compartments, i.e. sinus venosus (SV), atrium (A), atrio-
ventricular canal (AVC), ventricle (V) and outﬂow tract
(OFT). Post-mortem cortical brain tissue of eight control
persons and 10 Huntington disease patients was obtained
from Prof Dr R.A.C. Roos (Leiden University, the
Netherlands). Total RNA was isolated using RNAeasy
columns (Qiagen) according to the manufacturer’s instruc-
tions. The total RNA was treated with DNase RQ1
(Promega) and the integrity of the RNA was checked
Box 1. Equations used in the analysis of quantitative PCR data. The equations are numbered according to their appearance in the text.
The basic equation for PCR kinetics (Equation 1) states that the amount of amplicon after c cycles (Nc) is the starting concentration of the
amplicon (N0) times the ampliﬁcation eﬃciency (E) to the power c. The PCR eﬃciency in this equation is a number between 1 and 2 (2 indicates
100% eﬃciency). The PCR eﬃciency can be deﬁned as the increase in amplicon per cycle (Equation 5). During the exponential phase of the PCR
reaction this eﬃciency is constant. When a ﬂuorescence baseline is included in the PCR model (parameter BL in Equation 4), and the estimation
of the baseline is incorrect, the cycle-to-cycle eﬃciency contains a constant (B) in both the denominator and the numerator (Equation 6), which
leads to the observation of a biased eﬃciency. Equation 1 can be inverted (Equation 2) to calculate the starting concentration (N0) from the user-
deﬁned ﬂuorescence threshold (Nt), the eﬃciency and the fractional number of cycles needed to reach the threshold (Ct). This N0 is expressed in
arbitrary ﬂuorescence units. The starting concentration of amplicon A (N0,A) can be expressed relative to that of amplicon B (N0,B) by direct
division of these starting concentrations (Equations 3A and 3B). When the ﬂuorescence thresholds for both amplicons are equal, the expression
ratio in Equation 3B can be ‘simpliﬁed’ to Equation 3C. However, further reduction of the number of parameters leading to Equation 3D,
requires that the eﬃciencies of both amplicons (EA and EB) are equal. If this requirement is not met, a bias is introduced in the expression ratio
(Equation 7A). This bias is deﬁned as the real ratio (Equation 3C) divided by the biased ratio (Equation 3D). Rearrangement (Equation 7B) and
the assumption that Ecommon is the geometric mean of the amplicon eﬃciencies EA and EB then leads to Equation 7C. From this equation, it
follows that the bias introduced by ignoring the diﬀerence between amplicon eﬃciencies is an exponential function of the relative error of Ecommon
and the sum of the Ct values. Note that the application of Equations 2, 3B or 3C is mathematically equivalent to extrapolation of the regression
line(s) through the log-linear phase to cycle 0 (Figure 1A).
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using the BioAnalyzer and the Agilent RNA 6000 Nano
kit (II). A 1–0.5mg total RNA was converted into cDNA
using an anchored poly-dT primer and the Superscript II
(human samples) or III (chicken samples) Reverse tran-
scription kit (Invitrogen).
PCR reactions
The samples of the ‘Huntington Disease’ and the ‘serial
dilution’ data series were ampliﬁed in 96-well plates in an
Applied BioSystems ABI7300. The qPCR reaction was
done in 20 ml with primers for ATG5 (Forward: GGCC
ATCAATCGGAAACTCAT; Reverse: AGCCACAGGA
CGAAACAGCTT; product: 123bp), PSMB5 (Forward
TGTCCCAGAAGAGCCAGGAAT; Reverse: GCAAT
GTAAGCACCCGCTGTA; product 116 bp) or EEF1A1
(Forward: AAGCTGGAAGATGGCCCTAAA; Reverse:
AAGCGACCCAAAGGTGGAT; product: 54 bp),
Q-PCR SYBR Green Mastermix (Applied Biosystems)
in a concentration of 0.3mM. The used protocol was iden-
tical for all primer sets: 10min 958C, 40 (15 s 958C, 30 s
608C, 30 s 728C).
The samples of the ‘developing chicken heart’ dataset
were ampliﬁed in 384-well plates in a Roche
LightCycler480. The qPCR reaction was done in 10 ml
with a primer concentration of 1 mM and SYBR Green
qPCR Master Mix (Roche). The primers used were
NppB (Forward: GATGCCCAGGATGATGAGAG;
Reverse: CCTTGGGAGGATCAGGTTCT; product
157 bp), NDUFB3 (Forward: CTCGAGGAGGTCCAA
AGAAGGT; Reverse: GTGGCAGGTTTTGCATAG
CC; product 101 bp). These samples were measured in
three separated runs using the following protocol 5min
968C, 45 (10 s 958C, 20 s 588C, 20 s 728C).
PCR efficiency determination
The raw (i.e. not baseline-corrected) PCR data were used
in the analysis. Baseline correction was carried out with a
baseline trend based on a selection of early cycles or with
the algorithm developed in this study. The PCR eﬃciency
for each individual sample was derived from the slope of
the regression line ﬁtted to a subset of baseline-corrected
data points in the log-linear phase using LinRegPCR (15).
Algorithm development
Next to the three datasets mentioned above, 19 raw data-
sets of four diﬀerent qPCR platforms (2–10 datasets per
platform) were used in the development of a baseline esti-
mation algorithm. These datasets were selected because of
the presence of ‘diﬃcult’ samples. In these datasets, 56
diﬀerent targets were ampliﬁed (3–30 tissue samples per
amplicon per PCR run, 1–13 diﬀerent amplicons per run).
Ct values ranged from 4.5 up to 47. Several alternatives for
the developed method to estimate the baseline ﬂuorescence
were applied to each of the datasets to determine their
robustness. Similarly, the algorithm to set the Window-
of-Linearity (W-o-L) was tested on all datasets.
RESULTS
Baseline estimation
Baseline is deﬁned in this article as the level of ﬂuorescence
measured before any speciﬁc ampliﬁcation can be
detected. The raw qPCR data, i.e. the ﬂuorescence inten-
sities measured after each ampliﬁcation cycle, follow the
exponential model given by Equation 4 in which the base-
line is assumed to be constant for all cycles.
In the exponential phase of the PCR reaction, the
ampliﬁcation eﬃciency can theoretically be estimated
from cycle to cycle as E=Nc+1/Nc, which is the fold
increase in PCR product per cycle (Equation 5)
(10,22,23). When this cycle-to-cycle eﬃciency represents
the real eﬃciency in the current PCR run, an underesti-
mation of the baseline value will lead to the addition of a
positive constant in both the numerator and the denomi-
nator of the cycle-to-cycle eﬃciency (Equation 6), which
leads to an underestimation of the eﬃciency. In the same
way, an overestimation of the baseline leads to an over-
estimation of the PCR eﬃciency. A simple exercise
(Figure 1A and Supplementary Figure S1) shows that an
error in the baseline leads to a similar error in the observed
eﬃciency, whereas the resulting error in the N0 estimation
is about an order of magnitude larger.
Most PCR systems currently use a linear baseline trend
derived from a user-deﬁned set of early ampliﬁcation
cycles. Application of three baseline choices (‘baseline’
cycles 3–5, 3–10 and 3–15) to the three datasets results
in highly variable PCR eﬃciencies per amplicon
(Figure 2B, Supplementary Figures S2B, S3B and S4B).
The log-linear plots of the baseline-corrected datasets
show the characteristic convex and concave ampliﬁcation
curves that result from over- or underestimation of the
ﬂuorescence baseline (21) (Figure 2A; upper panel,
Supplementary Figures S2A, S3A and S4A). A baseline
based on a ﬁxed number of early observations always runs
the risk of being overestimated due to inclusion of ampli-
ﬁcation product.
Attempts to implement published algorithms, e.g. ref.
(5) to determine the baseline value from the ground cycles
prior to observable ampliﬁcation proved to be pointless
because of the noise and the behavior of the signal at the
start of the PCR (7). The very nature of the data in the
ﬁrst cycles, as well as the unknown chemistry and physics
underlying those data values, which display no reproduc-
ible trends from amplicon to amplicon, run to run and
platform to platform, eﬀectively prohibited the attempts
to develop a robust baseline estimation algorithm based
on the ground phase data (results not shown). The base-
line estimation algorithm we propose is based on the
assumption that ampliﬁcation eﬃciency is constant from
the very ﬁrst cycle onward. The cycle-dependent change in
eﬃciency that is predicted by some alternative analysis
models, e.g. refs (19,20,24), will be considered in the dis-
cussion. A constant PCR eﬃciency would, on a semi-
logarithmic plot, lead to a straight line of data points in
the whole log-linear phase. A proper baseline estimate will
therefore result in a dataset in which these points are on a
straight line (Figure 3B). Details on the baseline estima-
tion algorithm are given in Figure 3A. The algorithm is
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applied to each sample separately and does not include a
criterion on the value of the slope of the resulting log-
linear data points. However, when this baseline estimation
algorithm is applied to the three datasets, all datasets
show corrected data with ampliﬁcation curves that are
closely parallel per amplicon (Figure 2A, Supplementary
Figures S2A; lower panel, S3A and S4A).
Window-of-Linearity and fluorescence threshold
The residual measurement noise, even after optimal base-
line subtraction, still strongly aﬀects the ﬂuorescence
values at the lower end of the log-linear phase.
Therefore, a decision has to be made which data points
in the log-linear phase will be used for the estimation of
the PCR eﬃciency of each sample. In this article, these
data points will be referred to as the data points in the
W-o-L (15). Most PCR data analysis methods assume the
PCR eﬃciency to be the same for all samples per amplicon
and PCR run. Indeed, the variability in observed eﬃciency
values seems to reﬂect primarily a random error, and not a
real variation (16). Or, to quote Peirson and co-workers
(10), ‘one must assume that the ampliﬁcation eﬃciency is
comparable unless there is suﬃcient evidence to suggest
otherwise’.
Based on this consideration, the algorithm to set the
W-o-L searches for the window with the least variation
between eﬃciencies. This algorithm is illustrated in
Figure 4A. The procedure has to be carried out per ampli-
con, because the PCR eﬃciency can diﬀer per primer pair
and amplicon sequence. The window with the minimum
coeﬃcient of variation of eﬃciency values is chosen as
the optimal W-o-L. No criterion is set on the absolute
value of the eﬃciencies. However, in all datasets, the min-
imum variance coincides closely with a maximum mean
eﬃciency (Figure 4B, right). When the experimental
Figure 1. Eﬀect of baseline estimation errors in quantitative PCR data analysis. (A) The graph shows ampliﬁcation curves of a reference (closed
symbols, dashed lines) and a target gene (open symbols, solid lines) after subtraction of the correct and erroneous baselines. The diﬀerent intercepts
of the lines with the Y-axis illustrate the calculation of the starting concentration (N0) based on the observed PCR eﬃciency values (Box 1;
Equation 2). The table shows that with an independent and random baseline estimation error of up to 2%, in both the reference gene and the
target gene, the observed expression ratio varies from 0.7 to 9.5. Note that the extrapolation of the regression line(s) through the log-linear phase to
cycle 0 is mathematically equivalent to the application of Equations 2, 3B or 3C (Box 1). (B) Raw ﬂuorescence data of a PCR reaction with diﬀerent
primer concentrations. The curves show the ampliﬁcation of NppB in chicken heart tissue. The ﬂuorescence baseline increases with increasing primer
concentration. (C) Flowchart of the analysis of quantitative PCR data described in this article.
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condition is suspected to inﬂuence the PCR eﬃciency, a
W-o-L has to be set per condition and the resulting PCR
eﬃciencies should be compared.
The threshold cycle Ct, which is deﬁned as the fractional
PCR cycle at which a preset threshold of PCR product is
observed, has been the mainstay of qPCR data analysis
since the introduction of ﬂuorescence monitoring of
the PCR reaction (8). This Ct value is proportional to
the logarithm of the initial target concentration at con-
stant ampliﬁcation eﬃciency (Figure 1A, Equation 2).
The best reproducibility of the Ct value is achieved when
the ﬂuorescence threshold is placed in the upper part of
the log-linear phase (Supplementary Figure S3D). The
eﬀect of the baseline estimation on the observed Ct value
is small; even with a 30% baseline error, the observed Ct
values fall within a range of 0.3 cycles on either side of the
‘true’ Ct value (Supplementary Figure S1F).
The W-o-L algorithm was applied to all baseline-
corrected datasets and the resulting PCR eﬃciencies per
sample were plotted (Figure 2B). When the baseline was
corrected with the above described baseline estimation
algorithm, the variance among individual PCR eﬃciency
values was signiﬁcantly reduced compared to the variance
after baseline correction with a baseline trend based on
early cycles (Supplementary Figures S2B, S3B and S4B).
Ct values were only marginally aﬀected by diﬀerent base-
lines (Supplementary Figure S4D).
Amplification efficiency
The choice of the eﬃciency value to be used in qPCR data
analysis is a recurring theme in qPCR papers. In an exten-
sive hierarchical design, Karlen and co-workers (11)
showed that bias was removed and that high resolution,
Figure 2. Eﬀect of the baseline estimation method on qPCR data analysis. (A) PCR ampliﬁcation curves of NppB and NDUFB3 in samples of ﬁve
diﬀerent parts of the developing chicken heart. Baseline ﬂuorescence was estimated by the system software as a linear trend through the observations
of cycles 3 through 10 (BL 3–10, top panel) or with the baseline estimation method described in this article (LinRegPCR, bottom panel). See
Supplementary Figure S2A for additional system baseline settings.(B) PCR eﬃciency values of NppB and NDUFB3 from each individual sample
(open circles) in three independent PCR runs. An optimal W-o-L was applied per amplicon per plate. Mean eﬃciencies per plate and per amplicon
were calculated. PCR eﬃciencies were determined after application of three baseline trends, as well as after the LinRegPCR baseline subtraction. The
variation was lowest in LinRegPCR-derived PCR eﬃciency values (see Supplementary Figure S2B). (C) NppB/NDUFB3 gene expression ratio in
diﬀerent parts of the developing chicken heart for each of the baseline correction methods. Note that the pattern of observed expression ratios
depends on the applied baseline correction method. Variation in expression ratios per tissue is lowest in data derived from LinRegPCR-corrected
data.
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precision and robustness were reached when PCR eﬃcien-
cies of diﬀerent samples per amplicon were averaged
over all measurements done on one cDNA. Similarly,
Cikos and co-workers (12) showed that intra- and inter-
assay variability decreased when the individual eﬃciencies
were replaced by the mean eﬃciency per amplicon. These
recommendations were based on the estimation of PCR
eﬃciencies per sample in which each sample was ﬁtted
to its own W-o-L (15). However, setting the W-o-L
per amplicon already reduces the variation between
samples signiﬁcantly (Supplementary Figure S3B).
Diﬀerent W-o-L settings were compared to determine
which W-o-L to use, and which eﬃciencies to average.
A dataset of qPCR samples of brain tissue containing
Huntington patients and control samples served to study
the eﬀect of averaging eﬃciencies on the variation and the
bias of the reported concentrations for two amplicons.
Three diﬀerent window settings were used. We previously
proposed to base the W-o-L on the best-ﬁtting straight
line though 4–6 data points (15). This setting resulted in
Figure 3. Fluorescence baseline estimation. (A) Flowchart of the baseline estimation algorithm. For each sample, an initial baseline is set to the
minimum observed ﬂuorescence. Samples are skipped when less than seven times increase in ﬂuorescence values is observed. For each sample that
shows ampliﬁcation, an iterative algorithm than repeatedly adjusts the baseline value until the slope of the regression line through the data points in
the upper half of the exponential phase diﬀers less than 0.0001 from the slope of the line through the data points in the lower half. At a PCR
eﬃciency of 1.8, this criterion translates into an eﬃciency diﬀerence of 0.0004. The algorithm results in a set of data points on a straight line and
eﬀectively reconstructs the exponential phase. (B) Comparison of ampliﬁcation curves resulting from an optimal baseline (ﬁlled squares) with the
curves resulting from 1% to 5% over-estimated (gray and open triangles) and 1% to 5% under-estimated baselines (gray and open circles) showing
that the shape of the curves is dependent on the baseline estimate (21). This change in shape of the curve is used to estimate the optimal baseline (A).
(C) The graph shows the baseline values in both phases of the baseline estimation. (D) The graph shows the slopes of the regression lines through the
upper (Supper) and lower (Slower) halves of the continuous set of data points in the exponential phase when the baselines in (C) are applied.
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Figure 4. Setting the W-o-L. (A) Flowchart of the algorithm to determine the position of the W-o-L. The search for the optimal W-o-L starts with the
upper limit of this window set at the mean ﬂuorescence level found at the maximum of the second derivative (SDM) of the baseline-corrected ﬂuorescence
data. After application of this initial window, a loop is started in which the window is systematically lowered by half of the ﬂuorescence increase per cycle.
For each window, the coeﬃcient of variation (CV) is calculated from the mean and the standard deviation of the PCR eﬃciencies. The minimum CV
marks theW-o-L in which the PCR eﬃciencies of the samples show the least variation relative to the mean eﬃciency. (B) Intermediate results of theW-o-L
setting algorithm. The left panel shows the baseline-corrected ampliﬁcation curves of an example data set and the optimal W-o-L. The mean PCR
eﬃciency and its standard deviation are plotted for each W-o-L (right panel). The smallest CV, and thus the smallest between-sample PCR eﬃciency
variation, marks the optimal W-o-L. Data points at the beginning of the log-linear phase are preferentially present when a positive statistical noise carries
them just above baseline. Consequently, in a very low W-o-L those samples behave as if their baseline was under-estimated and they contribute a low
eﬃciency to the mean. This leads to the decrease of the mean eﬃciency in the lower-than-optimal windows.
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highly variable PCR eﬃciencies (Figure 5A, left). When
the W-o-L is set per amplicon, the variability between
individual PCR eﬃciencies is signiﬁcantly reduced
(Figure 5A, right) and neither amplicon showed a diﬀer-
ence in PCR eﬃciencies between Control and Huntington
patients (Supplementary Figure S4B). For both ampli-
cons, the frequency distribution of the observed PCR eﬃ-
ciencies is normal and symmetrical around the mean PCR
eﬃciency (Figure 5C). This justiﬁes the use of the mean of
these eﬃciencies as an estimate for the true PCR eﬃciency
per amplicon. For further discussion, the eﬃciency values
were also determined by setting a common window for
both amplicons (Figure 5A, middle) and a common
(mean) PCR eﬃciency (EC) was calculated, thus ignoring
the ampliﬁcation diﬀerence between amplicons.
The variability in estimated starting concentrations
(Figure 5B) is not statistically diﬀerent between the diﬀer-
ent W-o-L settings but there appears to be slightly less
variation in the analysis in which a common eﬃciency is
used (Figure 5B, middle). However, when for each sample
the ratio of the two starting concentrations is calculated,
the individual and the amplicon eﬃciencies result in sim-
ilar ratios, with a larger variability for the individual eﬃ-
ciencies (Figure 5D, left and right). The ratios resulting
from the common eﬃciency are signiﬁcantly lower
(Figure 5D, middle), which illustrates that ignoring the
Figure 5. Comparison of the use of individual, common or amplicon-speciﬁc PCR eﬃciencies. (A) PCR eﬃciency values for ATG5 (gray) and
PSMB5 (white) in controls and Huntington patients were based on the individual sample (individual window), a W-o-L for all samples from both
amplicons (common window) and a W-o-L set for each of the two amplicons (amplicon window). For each amplicon, the variation in PCR values
was highest in individual windows and lowest when a W-o-L per amplicon (F-test, P< 0.001 for both amplicons) was used. The mean eﬃciency per
amplicon did not diﬀer between the three W-o-L settings (one-way ANOVA; P=0.183 and P=0.101, respectively) but for all windows the
eﬃciencies of the two amplicons diﬀered signiﬁcantly (t-test: all P< 0.0001). EC indicates the common PCR eﬃciency that results when the diﬀerence
between amplicons is ignored. (B) Starting concentrations (N0 expressed in arbitrary ﬂuorescence units) in brain tissue for both amplicons in Controls
and Huntington patients calculated with the individual, common, and amplicon eﬃciency. There is no signiﬁcant diﬀerence between the variation in
N0 values per amplicon and experimental group although the variation is lowest when the common PCR eﬃciency was used. For both amplicons, the
starting concentrations are signiﬁcantly lower when the results were obtained with a common eﬃciency (t-test, P 0.001 for both amplicons and
comparisons). The N0 values do not diﬀer when they were obtained with individual or amplicon eﬃciencies (t-test, P=0.916 and P=0.994 for
ATG5 and PSMB5, respectively). (C) Frequency distributions of the individual PCR eﬃciency values determined with a W-o-L per amplicon. The
distribution of eﬃciency values is symmetrical and normally distributed (Shapiro–Wilk test; P=0.933 and P=0.478 for ATG5 and PSMB5,
respectively). (D) When the gene expression ratio (PSMB5/ATG5) in Controls and Huntington patients is based on the N0 values calculated with
the individual or the amplicon eﬃciency, the average ratios are similar (dotted lines), but the variation in the ratios is signiﬁcantly reduced when the
amplicon eﬃciencies are used [F-test on log(ratio); P=0.009]. When the expression ratio is calculated with the common eﬃciency the average ratio is
signiﬁcantly biased (t-test; P< 0.0001 compared to both the individual and the amplicon eﬃciency results). This bias results from ignoring the
diﬀerence between the amplicon eﬃciencies (Box 1; Equation 7).
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diﬀerence in PCR eﬃciency gives rise to biased ratio
results. The magnitude of this bias depends on the relative
diﬀerence between the amplicon eﬃciencies and the
common eﬃciency, as well as on the Ct values of the
two amplicons in the ratio (Equation 7).
Alternative data analysis approaches
The eﬃciency value used in the qPCR data analysis has to
be derived from the observed ampliﬁcation data. Some
papers report that a ‘mean’ eﬃciency can be calculated
from the slope of a standard curve, which is a plot of
observed Ct values versus the log-concentration of a
serial dilution of a standard sample (Figure 6A and 6B)
(2,8,25). The regression line ﬁtted to these data points is
then described by the equation Ct=log(Nc)/log(E)  1/
log(E) log(N0) which is Equation 2, log-transformed and
rearranged to show the linear dependence of Ct on
log(N0). However, this equation does not describe a
straight line with a ﬁxed slope when the ampliﬁcation
eﬃciencies of the samples are not all equal (18). In that
case, the presence of the log(E) variable in both the slope
and intercept term of the above equation will result in a
standard curve-derived eﬃciency that does not represent
the true mean PCR eﬃciency of the samples (Figure 6C)
(15,26). Accordingly, several authors reported that the
mean of the individual PCR eﬃciencies gave less biased
results than a standard curve-derived eﬃciency (10,11,26).
Figure 6. Bias in starting concentrations introduced by standard curve-derived PCR eﬃciency values or nonlinear analysis procedures. (A) PCR
ampliﬁcation curves of a serially diluted brain tissue sample (4 steps of 10 times dilution; 5 replicates per dilution) after baseline correction (see also
Supplementary Figure S3). (B) The standard curve scatter plot shows the Ct values plotted versus the known log-concentration of each serial dilution.
This series of ﬁve dilutions, measured in ﬁve replicates per dilution, was used to construct 3125 (=55) standard curves with one measurement per
dilution. (C) Frequency distribution of the eﬃciency values derived from the slopes of the 3125 standard curves. The diamond indicates the eﬃciency
value derived from the slope of the regression line ﬁtted to all 25 observations. Inset: The individual eﬃciencies of the 25 ampliﬁcation curves,
calculated from the data points in a common W-o-L. The arrow marks the mean of these individual PCR eﬃciencies. (D) Starting concentrations
(N0) calculated with the mean of the individual eﬃciency values (C; arrow in inset). Results were expressed relative to the mean N0 value of the
undiluted samples. The graph shows that these N0 values (grey circles) show a good correlation with the input values (observed = 0.962  input;
R2> 0.999). The N0 values calculated with the minimum (white circles) or maximum (black circles) eﬃciency derived from the standard curves show a
positive or negative bias, respectively. (E) The dilution series was analyzed with LinRegPCR (15) and with the Real-time PCR Miner application (7).
Miner performs a nonlinear ﬁt of Equation 4 (Box 1) to a subset of raw data points in the exponential phase. The PCR eﬃciency values resulting
from Miner and LinRegPCR are plotted (ﬁlled and open circles, respectively). The Miner results show an increasing PCR eﬃciency with lower input
concentrations (P< 0.001), LinRegPCR results do not (P=0.06). (F) Starting concentrations (N0) for the serial dilution dataset calculated by Miner
(open circles). The solid line is the regression through the starting concentrations observed with LinRegPCR (D; gray circles). The Miner results show
an increasing negative bias with lower input concentrations.
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A similar result was observed for the serial dilution dataset
in this study (Figure 6D).
Data analysis methods that are based on the application
of linear regression algorithms (10,15) require baseline
subtraction before the logarithmic transformation because
of the ﬁt of the logarithm of Equation 1 to a subset of data
in the exponential phase. In contrast, analysis methods
based on nonlinear curve ﬁtting do not require such an
a priori baseline subtraction because the ﬁtted mathemat-
ical models contain an additive term (i.e. y0 or Fb) that
represents a constant (6,27,28) or cycle-dependent baseline
(5,19). These algorithms were applied to raw data (5) as
well as data that were baseline corrected by the system
software (6,20,28,29). In the latter papers the baseline
term is, therefore, ignored (or set to zero) in the derivation
of additional equations. This practice might lead to the
erroneous opinion that these analysis approaches are inde-
pendent of the proper handling of the ﬂuorescence
baseline.
Several authors use a sigmoid or logistic curve ﬁt to
select the data points in the exponential phase and then
use nonlinear curve ﬁtting to ﬁt the exponential equation
[FC=Fb+F0EC (Equation 4)] to determine the PCR
eﬃciency E (5,7). The start of the dataset used for this ﬁt is
deﬁned as the ﬁrst point above the ground phase noise
which leads to an overestimation of the baseline parameter
(Fb). The risk implied in the direct ﬁtting of Equation 4 is
that the balance between the two additive parts of this
equation is determined by the input concentration of
the amplicon (F0); when the baseline is overestimated,
the second term in the equation has to compensate.
Especially, for low starting concentrations this compensa-
tion has to be found in a high eﬃciency value. Examples of
the resulting upward trend of eﬃciency values with
decreasing starting concentration can be found in litera-
ture, e.g. (19,24). The application of this nonlinear ﬁt [i.e.
Miner (7)] to the serial dilutions dataset also shows such a
relation between input concentration and PCR eﬃciency
(Figure 6E). Starting concentrations, calculated with these
eﬃciency values, show an increasingly strong negative bias
with lower input concentrations (Figure 6F). The same
data were analyzed with the method described in this arti-
cle and show a constant PCR eﬃciency, irrespective of the
input concentration (Figure 6E).
The nonlinear ﬁt of the exponential equation
(Equation 4) (5,7,24) diﬀers from the method described
in the current article only because we propose a two step
approach: ﬁrst ﬁnd an estimate for the baseline value and
then ﬁt the PCR ampliﬁcation equation (Equation 1) to
the baseline-subtracted data. The logarithmic approach
used in our baseline estimation method gives more
weight to the low, close to baseline, observations; con-
structing a straight line down from the start of the plateau
phase thus leads to a more precise estimate of the baseline.
DISCUSSION
Currently, the mainstream of analysis of qPCR data is
based on the Ct value of each sample and a PCR eﬃciency
value per amplicon. Application of a calculation equation
derived from Equation 1 then leads to an estimate of the
starting concentration expressed in arbitrary ﬂuorescence
units or an estimate of the ratio between two starting
concentrations of the transcript-of-interest (Equation 2
and Equations 3B or 3C, respectively). This article deals
with the analysis of qPCR data resulting from the mon-
itoring of DNA binding dyes like SYBR Green I, but most
of the principles discussed in this article also apply to data
collected with other ﬂuorescent chemistries (e.g. hydrolysis
probes). However, analysis of such data sets requires extra
data processing steps that are not discussed in this text.
Analysis of qPCR data requires the derivation of a PCR
eﬃciency value from the observed data. This article shows
that the observed PCR eﬃciency is strongly inﬂuenced by
small errors in the applied baseline correction. As
described, it proves impossible to estimate a baseline
value from the so-called ground phase data because the
source of this ﬂuorescence is not clear. The main source of
baseline ﬂuorescence is unbound ﬂuorochrome (e.g.
SYBR Green), which is not fully nonﬂuorescent (4).
However, baseline ﬂuorescence also depends on sample
dilution, and thus on total cDNA concentration, and on
primer concentration (Figure 1B). Together with the uni-
dentiﬁed interactions between those ﬂuorescence sources,
the prediction and modeling of baseline behavior is cur-
rently unfeasible. Our conclusion that there is not enough
ground for the development of an algorithm to determine
the baseline from the ground phase data is in line with the
ﬁndings of others (7).
The baseline estimation algorithm described in the
current article is based on the kinetic model of PCR ampli-
ﬁcation (Equation 1) and a constant PCR eﬃciency.
Cycle-dependent changes in PCR eﬃciency are predicted
by sigmoid models used in qPCR analysis (20,28,29). The
use of such sigmoid models is not based on biophysical/
biochemical considerations of PCR kinetics, but mainly
on their good ﬁt to raw qPCR data. Recent papers show
that despite their overall good ﬁt, these models do not ﬁt
well to the exponential phase data (7,29). Therefore, these
‘empirical’ models do not provide a solid basis for
modeling of the behavior of the PCR eﬃciency during
the PCR reaction. On the other hand, it was established
that, when modeling PCR as a statistical branching
process, PCR eﬃciency is constant from the ﬁrst cycle
until the beginning of the plateau phase (30). A modeling
study based on kinetic annealing conﬁrmed this notion
(23). Moreover, the N0 value estimated with Equation 2,
at large enough Ct, has been shown to be an unbiased
estimate of the real starting amount (22).
With a constant PCR eﬃciency the value of each data
point up till the start of the plateau phase is the sum of the
baseline ﬂuorescence and an exponentially increasing
amplicon-dependent ﬂuorescence (Equation 4). An algo-
rithm that searches for a baseline value that results in the
longest straight line of data points when plotted on a semi-
logarithmic scale, isolates the exponentially increasing
part of the observed ﬂuorescence values. This algorithm
requires a suﬃciently large baseline-to-plateau ratio as
well as a low observation noise. In datasets that do not
fulﬁll these requirements a reliable straight line in the log-
linear phase will not be found. The baseline value can be
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lowered by lowering the primer concentration (Figure 1B);
observation noise can be reduced by setting a ﬁxed,
instead of an adaptive, exposure time in the qPCR appa-
ratus. Note that the baseline estimation algorithm does
not include a ‘goodness-of-ﬁt’ criterion. The chosen algo-
rithm ensures that points at lower cycle numbers are only
included as long as they randomly deviate from the
straight line deﬁned by the points in the upper part of
the exponential phase. Such a provision would not be
possible when the algorithm includes a ‘goodness-of-ﬁt’
criterion for the whole log-linear phase.
Even after minimizing PCR eﬃciency variability and
setting of a W-o-L per amplicon, similar samples show
slightly diﬀerent observed PCR eﬃciencies. To the best
of our knowledge, no sample-dependent PCR eﬃciency
diﬀerences have ever been reported (10,31). Variability
of the PCR eﬃciency values has been attributed to a lim-
ited precision of individual data (12) and thus reﬂects
mainly a statistical error and not a real diﬀerence (16).
Accordingly, most researchers choose to use a ﬁxed or
the mean eﬃciency per amplicon in their analysis of
qPCR data. The symmetric distribution of the individual
eﬃciency values (e.g. Figure 5B and inset of Figure 6C)
justiﬁes using the arithmetic mean eﬃciency. Although the
use of a ﬁxed PCR eﬃciency for all samples per amplicon
is well supported, it is still important to use an eﬃciency
value that represents the true eﬃciency. Equation 7
shows that the bias in the expression ratio resulting from
using a common eﬃciency value for two amplicons,
instead of the amplicon-speciﬁc eﬃciencies, depends on
the relative diﬀerence in eﬃciencies as well as the Ct
values of both samples. An example of such a bias is illu-
strated in Figure 5D.
Based on the results and considerations in the current
paper, the LinRegPCR analysis program (15) has been
updated. Although this updated version of the program
can be used in a ‘load-and-click’ mode, the diﬀerent vari-
ation sources in qPCR analysis make that no analysis
system can be used as a black box. Every user of qPCR
should stay aware of hitherto unknown variables aﬀecting
the analysis. The experimental set-up should be aimed at
recognizing the variables of interest and should enable the
analysis of the signiﬁcance of such variables. Analysis sys-
tems cannot relief the researcher of this task.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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